Abstract
This study tests the hypothesis that methylprednisolone may influence eNOS activity in renal arterial and venous vascular beds and impede subclinical renal injury. Acute renal failure is a major complication of cardiovascular surgery. Renal damage arises in part from excessive vasoconstriction mediated by an imbalance of vasoconstrictive ET-1 and vasodilatory NO produced by eNOS. While methylprednisolone may reduce subclinical renal injury as measured by urinary N-acetyl-beta-D-glucosaminidase (beta-NAG), its effects upon eNOS activity in renal arterial and venous vascular beds, reflected by urinary nitrate levels, is unclear. A porcine model of normotensive, euvolemic infrarenal aortic ischaemia-reperfusion was used. Forty-two pigs underwent a 60-minute laparotomy followed by 150 minutes of infrarenal ischemia and 180 minutes of reperfusion. Animals were randomized to receive methylprednisolone 30 mg/kg or placebo after induction of general anesthesia. Urinary beta-NAG levels were assessed as an index of subclinical renal injury, whereas urinary nitrate was assessed as an indicator of eNOS activity in renal arterial and venous vascular beds. Methylprednisolone treatment did not influence mean arterial, central venous, or pulmonary artery wedge pressures but suppressed plasma IL-6 levels. After the ischemia-induced rise from preanaesthetic baseline levels, urinary beta-NAG levels declined to significantly lower values in the MP group, indicative of MP renal protection (P < 0.05). Conversely, urinary nitrate levels indicative of vascular e-NOS activity remained significantly and persistently higher in MP-treated animals (P < 0.05). This study, in a porcine model of renal ischaemia-reperfusion injury, shows the benefits of methylprednisolone pretreatment in enhancing urinary nitrate levels indicative of vascular eNOS activity and the reduction of urinary beta-NAG levels, which represent subclinical renal injury.
MeSH Terms
Acetylglucosaminidase/urine
Acute Kidney Injury/etiology,prevention & control,urine
Animals
Aorta, Abdominal
Biomarkers/urine
Disease Models, Animal
Follow-Up Studies
Glucocorticoids/therapeutic use
Kidney/blood supply
Methylprednisolone/therapeutic use
Nitrates/urine
Reperfusion Injury/complications,drug therapy,urine
Severity of Illness Index
Spectrophotometry
Swine
Treatment Outcome
Chemicals
Biomarkers
Glucocorticoids
Nitrates
Acetylglucosaminidase
Methylprednisolone
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Armstrong Marilyn A
Young Ian S
McClean Elizabeth
O'Rourke Declan
Campbell Frederick C
D'Sa Aires A B Barros
McBride William T
References (19)
19 references, click to expand
-
Plasma and urinary cytokine homeostasis and renal dysfunction during cardiac surgery.
Anesthesiology. 2000 Nov;93(5):1210-6; discussion 5A
PMID: 11046208
-
Endogenous interleukin-6 enhances the renal injury, dysfunction, and inflammation caused by ischemia/reperfusion.
J Pharmacol Exp Ther. 2005 Mar;312(3):1170-8
PMID: 15572648
-
Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase.
Nat Med. 2002 May;8(5):473-9
PMID: 11984591
-
Relative roles of endothelin-1 and angiotensin II in experimental post-ischaemic acute renal failure.
Nephrol Dial Transplant. 2004 Jan;19(1):83-94
PMID: 14671043
-
Methylprednisolone favourably alters plasma and urinary cytokine homeostasis and subclinical renal injury at cardiac surgery.
Cytokine. 2004 Jul 21-Aug 7;27(2-3):81-9
PMID: 15242697
-
Enzymuria as a marker of renal injury and disease: studies of N-acetyl-beta-glucosaminidase in the general population and in patients with renal disease.
Pediatrics. 1978 Nov;62(5):751-60
PMID: 364392
-
The role of different types of corticosteroids on the inflammatory mediators in cardiopulmonary bypass.
Eur J Cardiothorac Surg. 1991;5(4):211-7
PMID: 1711873
-
Measurement of N-acetyl-beta-glucosaminidase and its isoenzymes in urine methods and clinical applications.
Eur J Clin Chem Clin Biochem. 1992 Oct;30(10):693-705
PMID: 1493161
-
The role of NAG (N-acetyl-beta-D-glucosaminidase) in the diagnosis of kidney disease including the monitoring of nephrotoxicity.
Clin Nephrol. 1992;38 Suppl 1:S14-9
PMID: 1295704
-
Suppression by methylprednisolone of augmented plasma endotoxin-like activity and interleukin-6 during cardiopulmonary bypass.
Br J Anaesth. 1994 Mar;72(3):348-50
PMID: 8130057
-
Tubular nephrotoxicity after cardiac surgery utilising cardiopulmonary bypass.
Clin Chim Acta. 1994 Aug;228(2):123-32
PMID: 7988029
-
Urinary excretion of thromboxane and markers for renal injury in patients undergoing cardiopulmonary bypass.
Artif Organs. 1994 Aug;18(8):565-9
PMID: 7527629
-
Methylprednisolone inhibits increase of interleukin 8 and 6 during open heart surgery.
Can J Anaesth. 1995 May;42(5 Pt 1):399-403
PMID: 7614647
-
Toward a biochemical understanding of human intervertebral disc degeneration and herniation. Contributions of nitric oxide, interleukins, prostaglandin E2, and matrix metalloproteinases.
Spine (Phila Pa 1976). 1997 May 15;22(10):1065-73
PMID: 9160463
-
Effect of methylprednisolone on the oxidative burst activity, adhesion molecules and clinical outcome following open heart surgery.
Scand Cardiovasc J. 1997;31(5):283-8
PMID: 9406295
-
Pulmonary effects of methylprednisolone in patients undergoing coronary artery bypass grafting and early tracheal extubation.
Anesth Analg. 1998 Jul;87(1):27-33
PMID: 9661540
-
Influence of methylprednisolone on cytokine balance during cardiac surgery.
Crit Care Med. 1999 Mar;27(3):545-8
PMID: 10199534
-
Cytokine-induced venodilatation in humans in vivo: eNOS masquerading as iNOS.
Cardiovasc Res. 1999 Mar;41(3):754-64
PMID: 10435048
-
Dexamethasone inhibits stimulation of pulmonary endothelins by proinflammatory cytokines: possible involvement of a nuclear factor kappa B dependent mechanism.
Intensive Care Med. 2001 Apr;27(4):751-6
PMID: 11398704